← Back to Search

HFO analysis for Pediatric Epilepsy (HFO Trial)

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year after surgery
Awards & highlights

HFO Trial Summary

This trial is testing whether adding HFO monitoring to standard clinical practice during epilepsy surgery results in better seizure control.

Eligible Conditions
  • High Frequency Oscillation
  • Pediatric Epilepsy
  • Epilepsy Surgery

HFO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-operative Seizure-free Rate
Secondary outcome measures
Post-operative Complication

HFO Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of Care PLUS HFOExperimental Treatment1 Intervention
Surgery is tailored by HFOs and standard ECoG interpretation (spikes on intra-operative ECoG or seizure onset on extra-operative ECoG) (arm 1).
Group II: Standard of CareActive Control1 Intervention
Surgery is tailored by standard ECoG alone (arm 2).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HFO analysis
2018
N/A
~20

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,526 Previous Clinical Trials
10,275,887 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project currently open to volunteers?

"According to clinicaltrials.gov, this research project is not currently recruiting participants. The trial was published on November 29th 2018 and has been amended as of April 7 2021; however, there are 238 additional trials that are presently enrolling candidates."

Answered by AI

Who qualifies to partake in this clinical investigation?

"This experiment is looking for 30 participants, aged 0-21 and diagnosed with epilepsy, that meet the following conditions: refractory focal epilepsy; planned resective surgery approved by a medical board; intraoperative or extraoperative electrocorticography."

Answered by AI

Is eligibility for this trial limited to those over forty years old?

"This medical trial is seeking paediatric patients aged 0 to 21 years old."

Answered by AI
~3 spots leftby Apr 2025